# FOSCARNET SODIUM

NDC: 43066-089
Generic name: foscarnet sodium
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20230828

FDA application: ANDA213001

## Active ingredients

- FOSCARNET SODIUM: 6000 mg/250mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43066-089"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43066-089
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a7caffd-9d8a-4d45-ad48-70d511a89c29